Eark.Bo

EARK.BO maintains a conservative capital structure with a debt-to-equity ratio of 0.25, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 2.65, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.

In terms of profitability, EARK.BO demonstrates strong returns, with a return on equity of 69.11% and a return on assets of 45.43%. These figures significantly exceed the typical performance metrics for the Advanced Medical Equipment & Technology industry, indicating efficient use of equity and assets to generate profits.

The company's revenue is concentrated within a single business segment, as disclosed in its financial statements, with no geographic diversification reported. This lack of diversification may expose the company to higher operational and market risks if the segment faces challenges.

EARK.BO's growth trajectory is supported by a positive free cash flow of 136,589,000 INR, which provides flexibility for reinvestment or shareholder returns. However, the company's capital expenditure of -5,345,000 INR suggests a reduction in investment in long-term assets, which could impact future growth potential.

The company's risk profile is marked by a medium liquidity risk and a low dilution risk. The negative net cash position after debt is a key flag, indicating that the company may need to raise additional capital or manage its debt more effectively. No significant dilution sources are identified in the latest filings, and the dilution potential remains low.

Recent events, as disclosed in the latest financial filings, show a stable financial position with no major operational disruptions reported. The company's operating cash flow of 14,226,000 INR supports its ongoing operations, but the negative net cash position remains a concern.